Vimarsana
Biggest News Aggregation in the World

Mission Implementation Unit News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mission Implementation Unit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mission Implementation Unit Today - Breaking & Trending Today

Omicron: Drug controller gives emergency-use approval to booster vaccine for Omicron variant | India News - Vimarsana News

Omicron: Drug controller gives emergency-use approval to booster vaccine for Omicron variant | India News

India News: NEW DELHI: India's drug controller has granted emergency use authorisation for the Omicron-specific mRNA-based booster vaccine developed by Gennova Bi.

Drug controller's nod for Omicron-specific mRNA-based vaccine - Vimarsana News

Drug controller's nod for Omicron-specific mRNA-based vaccine

India's drug controller has granted emergency use authorisation for the Omicron-specific mRNA-based booster vaccine developed by Genova.

Source: siasat.com
DCGI grants EUA to Omicron-specific mRNA-based booster vaccine - Vimarsana News

DCGI grants EUA to Omicron-specific mRNA-based booster vaccine

The Department of Biotechnology (DBT) has announced that the Omicron-specific mRNA-based Booster vaccine developed using the indigenous platform technology by Gennova Biopharmaceuticals Ltd. and supported under the Mission COVID Suraksha, implemented by Biotechnology Industry Research Assistance Council (BIRAC), has got a nod from the office of the Drug Control General of India (DCGI) for Emergency Use Authorization (EUA).

Lessons from the Coronavirus Pandemic: Leveraging Biotechnology to Tackle Infectious Diseases in India - Vimarsana News

Lessons from the Coronavirus Pandemic: Leveraging Biotechnology to Tackle Infectious Diseases in India

In India, biotechnology has played an important role in helping stakeholders in academia, industry, and government develop new pandemic-related technology, from test kits to respiratory devices. But these biotechnology advancements can go further to strengthen India’s public health capacity.

Department of Biotechnology provides under Mission COVID Suraksha for Gennova Biopharmaceuticals Ltd.'s novel mRNA-based COVID 19 Vaccine candidate –HGCO19. – India Education| Global Education |Education News - Vimarsana News

Department of Biotechnology provides under Mission COVID Suraksha for Gennova Biopharmaceuticals Ltd.'s novel mRNA-based COVID 19 Vaccine candidate –HGCO19. – India Education| Global Education |Education News

Share Vaccine Discovery Programme supported by the Department of Biotechnology, Govt. of India under the Mission COVID Suraksha- The Indian COVID-19 Vaccine Development Mission, implemented by BIRAC, moves into clinical trials The Department of Biotechnology (DBT), Ministry of Science & Technologyhas announced that it has approved additional funding towards clinical studies of India’s’first of its kind’ mRNA-based COVID-19 vaccine – HGCO19, developed by Pune-based biotechnology company Gennova Biopharmaceuticals Ltd. This funding has been awarded under the’Mission COVID Suraksha- Th...